Order Article Reprints

Fukushima Y, Shimizu T, Kakubari T, Kumasaka S, Ozaki D, Sato Y, Takeuchi T, Motegi M, Chikamatsu K, Tsushima Y. Pretreatment L3 Skeletal Muscle Index Is Associated with Severe Oral Intake Impairment and a Longer Treatment-to-Discharge Interval in Patients with Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy. Cancers. 2026; 18(16):2677. https://doi.org/10.3390/cancers18162677

Fukushima, Yasuhiro, Tomohiro Shimizu, Tomotaka Kakubari, Soma Kumasaka, Daisuke Ozaki, Yusuke Sato, Tomokazu Takeuchi, Masaomi Motegi, Kazuaki Chikamatsu, and Yoshito Tsushima. 2026. "Pretreatment L3 Skeletal Muscle Index Is Associated with Severe Oral Intake Impairment and a Longer Treatment-to-Discharge Interval in Patients with Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy" Cancers 18, no. 16: 2677. https://doi.org/10.3390/cancers18162677

Fukushima, Y., Shimizu, T., Kakubari, T., Kumasaka, S., Ozaki, D., Sato, Y., Takeuchi, T., Motegi, M., Chikamatsu, K., & Tsushima, Y. (2026). Pretreatment L3 Skeletal Muscle Index Is Associated with Severe Oral Intake Impairment and a Longer Treatment-to-Discharge Interval in Patients with Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy. Cancers, 18(16), 2677. https://doi.org/10.3390/cancers18162677